Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 2
1984 3
1986 6
1987 5
1988 3
1989 2
1990 2
1991 1
1992 1
1993 1
1994 1
1999 3
2000 5
2001 5
2002 9
2003 3
2004 2
2005 1
2006 5
2007 2
2008 2
2013 1
2014 4
2015 3
2016 1
2017 1
2018 2
2019 2
2020 3
2021 5
2022 5
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Results by year

Filters applied: . Clear all
Page 1
Characterization of adverse joint outcomes in patients with osteoarthritis treated with subcutaneous tanezumab.
Carrino JA, McAlindon TE, Schnitzer TJ, Guermazi A, Hochberg MC, Conaghan PG, Brown MT, Burr A, Fountaine RJ, Pixton GC, Viktrup L, Verburg KM, West CR. Carrino JA, et al. Among authors: verburg km. Osteoarthritis Cartilage. 2023 Dec;31(12):1612-1626. doi: 10.1016/j.joca.2023.08.010. Epub 2023 Aug 29. Osteoarthritis Cartilage. 2023. PMID: 37652258 Free article.
Pharmacology of cyclooxygenase-2 inhibition in the kidney.
Khan KN, Paulson SK, Verburg KM, Lefkowith JB, Maziasz TJ. Khan KN, et al. Among authors: verburg km. Kidney Int. 2002 Apr;61(4):1210-9. doi: 10.1046/j.1523-1755.2002.00263.x. Kidney Int. 2002. PMID: 11918727 Free article. Review.
Response to: 'Use of tanezumab for patients with hip and knee osteoarthritis with reference to a randomised clinical trial by Berenbaum and colleagues' by Riddle and Perera.
Berenbaum F, Blanco FJ, Guermazi A, Miki K, Yamabe T, Viktrup L, Junor R, Carey W, Brown MT, West CR, Verburg KM. Berenbaum F, et al. Among authors: verburg km. Ann Rheum Dis. 2022 Apr;81(4):e66. doi: 10.1136/annrheumdis-2020-217629. Epub 2020 May 18. Ann Rheum Dis. 2022. PMID: 32424029 No abstract available.
Observed efficacy and clinically important improvements in participants with osteoarthritis treated with subcutaneous tanezumab: results from a 56-week randomized NSAID-controlled study.
Neogi T, Hunter DJ, Churchill M, Shirinsky I, White A, Guermazi A, Omata M, Fountaine RJ, Pixton G, Viktrup L, Brown MT, West CR, Verburg KM. Neogi T, et al. Among authors: verburg km. Arthritis Res Ther. 2022 Mar 29;24(1):78. doi: 10.1186/s13075-022-02759-0. Arthritis Res Ther. 2022. PMID: 35351194 Free PMC article. Clinical Trial.
88 results